跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,877 条关于
“RenMab”
全部
8,877
临床试验
8,601
药物
57
机构
24
资讯
195
去年
Biocytogen Secures Japan Patent for RenMab Platform, Strengthening Global IP Portfolio for Fully Human Antibody Discovery
6个月前
Biocytogen Reaches Clinical Milestone as First Patient Dosed in IDEAYA's B7H3/PTK7 Bispecific ADC Phase 1 Trial
去年
Biocytogen and Nanjing Chia Tai Tianqing Receive IND Approval for Second-Generation Anti-IGF-1R Antibody NTB003 in Thyroid Eye Disease
5个月前
Biocytogen Partners with Moonlight Bio to Develop Advanced Cell Therapies for Difficult-to-Treat Cancers
去年
Genmab Expands Antibody Pipeline Following ProfoundBio Deal, Plans Further Acquisitions
8个月前
Genmab Discontinues Acasunlimab Development to Focus on Late-Stage Pipeline Programs
去年
Genmab Plans FDA Submission for Epcoritamab Combination Therapy in Relapsed Follicular Lymphoma
去年
AbbVie Files Trade Secret Lawsuit Against Genmab Over ADC Technology in Cancer Drug Development
去年
Genmab to Present Extensive Epcoritamab Clinical Data at 2025 European Hematology Association Congress
去年
Genmab's Epcoritamab Shows Promise in Diffuse Large B-Cell Lymphoma Trials
第 1 页,共 20 页
上一页
下一页